BW
ZVSA

Boaz Weinstein’s ZyVersa Therapeutics ZVSA Stock Holding History

Boaz Weinstein’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,705
Closed -$5.97M – 951
2022
Q3 		$5.97M Buy
1,705
+36
+2% +$126K 0.07% 484
2022
Q2 		$5.8M Buy
1,669
+314
+23% +$1.09M 0.07% 481
2022
Q1 		$4.7M Buy
+1,355
New +$4.69M 0.07% 447

Other funds holding ZVSA

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Boaz Weinstein's ZVSA Position: Q4 2022 in Review

Boaz Weinstein sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 1,705 shares — an estimated $5.97M sold.

Boaz Weinstein first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $5.97M in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

  • Boaz Weinstein reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Boaz Weinstein sold 1,705 ZyVersa Therapeutics shares in Q4 2022, an estimated $5.97M.
  • Boaz Weinstein first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
  • Boaz Weinstein's ZyVersa Therapeutics position peaked at $5.97M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.